Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biomolecules ; 14(4)2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38672443

RESUMO

Paraoxonase-1 (PON1), a serum antioxidant enzyme, has been implicated in Alzheimer's disease (AD) pathogenesis that involves early oxidative damage. Corinthian currants and their components have been shown to display antioxidant and other neuroprotective effects in AD. We evaluated the effect of a Corinthian currant paste-supplemented diet (CurD), provided to 1-month-old 5xFAD mice for 1, 3, and 6 months, on PON1 activity and levels of oxidation markers in serum and the brain of mice as compared to a control diet (ConD) or glucose/fructose-matched diet (GFD). Administration of CurD for 1 month increased PON1 activity and decreased oxidized lipid levels in serum compared to ConD and GFD. Longer-term administration of CurD did not, however, affect serum PON1 activity and oxidized lipid levels. Furthermore, CurD administered for 1 and 3 months, but not for 6 months, increased PON1 activity and decreased free radical levels in the cortex of mice compared to ConD and GFD. To probe the mechanism for the increased PON1 activity in mice, we studied the effect of Corinthian currant polar phenolic extract on PON1 activity secreted by Huh-7 hepatocytes or HEK293 cells transfected with a PON1-expressing plasmid. Incubation of cells with the extract led to a dose-dependent increase of secreted PON1 activity, which was attributed to increased cellular PON1 expression. Collectively, our findings suggest that phenolics in Corinthian currants can increase the hepatic expression and activity of antioxidant enzyme PON1 and that a Corinthian currant-supplemented diet during the early stages of AD in mice reduces brain oxidative stress.


Assuntos
Doença de Alzheimer , Antioxidantes , Arildialquilfosfatase , Encéfalo , Modelos Animais de Doenças , Animais , Arildialquilfosfatase/metabolismo , Arildialquilfosfatase/genética , Doença de Alzheimer/metabolismo , Camundongos , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Encéfalo/metabolismo , Encéfalo/efeitos dos fármacos , Humanos , Camundongos Transgênicos , Estresse Oxidativo/efeitos dos fármacos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA